KHC vs QNCX · P/E 12, rev $12.31B vs $79.3M cap
Kraft Heinz Co (KHC) versus Quince Therapeutics, Inc. (QNCX) — a side-by-side from cached financials, not a winner call.
Kraft Heinz Co (KHC) is a packaged foods company listed on US.
Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.
Latest reported KHC revenue for 2026-06-27 was $12.31B. Net income was -$4.66B. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
QNCX does not have a complete income-statement cache yet.
KHC currently screens at market cap $31.55B and trailing P/E 12.2. QNCX currently screens at market cap $79.3M.
Not investment advice. Open the KHC and QNCX stock pages for the full models.
Not investment advice.